Pancreatic Cancer Research

ResearcherPennsylvania State UniversityActive in the last 2 years

June S. Peng

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-1891-4199; OpenAlex author ID A5046795757. Sources: OpenAlex.

Their work

Papers
9 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
19
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: 1 paper · 2020: none · 2021: 4 papers · 2022: none · 2023: none · 2024: 3 papers

Papers 9

  1. Disparities in Surgical Treatment of Resectable Pancreatic Adenocarcinoma at Minority Serving Hospitals. Co-author DOI 10.1016/j.jss.2023.09.066↗
  2. Complete response to chemotherapy in a 6-year survivor of metastatic pancreatic cancer. Last author DOI 10.1136/bcr-2024-261008↗
  3. Adult Pancreatoblastoma: Clinical Insights and Outcomes Compared to Pancreatic Ductal Adenocarcinoma (PDAC). Co-author DOI 10.3390/curroncol31090370↗
  4. Pathologic upstaging in resected pancreatic adenocarcinoma: Risk factors and impact on survival. Co-author DOI 10.1002/jso.26481↗
  5. Neoadjuvant chemoradiation is associated with decreased lymph node ratio in borderline resectable pancreatic cancer: A propensity score matched analysis. Co-author DOI 10.1016/j.hbpd.2020.08.001↗
  6. Undertreatment of Pancreatic Cancer: Role of Surgical Pathology. Co-author DOI 10.1245/s10434-020-09043-y↗
  7. Adjuvant Chemotherapy After Neoadjuvant Chemotherapy for Pancreatic Cancer is Associated with Improved Survival for Patients with Low-Risk Pathology. Co-author DOI 10.1245/s10434-020-09546-8↗
  8. Pathologic tumor response to neoadjuvant therapy in borderline resectable pancreatic cancer. Co-author DOI 10.1016/j.hbpd.2019.05.007↗
  9. Diagnostic Laparoscopy Prior to Neoadjuvant Therapy in Pancreatic Cancer Is High Yield: an Analysis of Outcomes and Costs. Co-author DOI 10.1007/s11605-017-3470-6↗

Closest collaborators

The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Chan Shen · 4 shared papers, 2021–2024 · strength 0.68
  2. Elizabeth Josephine Olecki · 4 shared papers, 2021–2024 · strength 0.68
  3. Matthew E. B. Dixon · 4 shared papers, 2021–2024 · strength 0.68
  4. Niraj Jaysukh Gusani · 3 shared papers, 2021 · strength 0.45
  5. Sricharan Chalikonda · 3 shared papers, 2017–2021 · strength 0.33
  6. Richard Matthew Walsh · 3 shared papers, 2017–2021 · strength 0.33
  7. Gareth J Morris‐Stiff · 3 shared papers, 2017–2021 · strength 0.33
  8. Cynthia E. Burke · 1 shared paper, 2024 · strength 0.31
  9. Nelson S. Yee · 1 shared paper, 2024 · strength 0.31
  10. Madeline B. Torres · 2 shared papers, 2021 · strength 0.30
  11. Han Yin · 1 shared paper, 2024 · strength 0.18
  12. Mohamed A. Adam · 1 shared paper, 2024 · strength 0.18
  13. Adnan A. Alseidi · 1 shared paper, 2024 · strength 0.18
  14. Ajay V. Maker · 1 shared paper, 2024 · strength 0.18
  15. Amir Ashraf‐Ganjouei · 1 shared paper, 2024 · strength 0.18
  16. Jane Wang · 1 shared paper, 2024 · strength 0.18
  17. Eric K. Nakakura · 1 shared paper, 2024 · strength 0.18
  18. Kimberly Saunders Kirkwood · 1 shared paper, 2024 · strength 0.18
  19. Daniela S. Allende · 1 shared paper, 2019 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.